Gainers & Losers
Thu Jul 10 2025 08:38:32- Indusind Bank share price
- ₹854.001.57%
- Maruti Suzuki India share price
- ₹12,660.151.54%
- Tata Steel share price
- ₹161.151.35%
- Bajaj Finserv share price
- ₹2,046.701.02%
- Bajaj Finance share price
- ₹949.851.00%
Active Stocks
Thu Jul 10 2025 08:38:30- Adani Power share price
- ₹607.350.86%
- Vedanta share price
- ₹437.05-0.85%
- Tata Steel share price
- ₹161.101.32%
- Tata Motors share price
- ₹693.350.07%
- Gail India share price
- ₹185.800.41%
Business News/Market/Market Stats/Emcure Pharmaceuticals share price/ Emcure Pharmaceuticals Profit Loss Annual
Emcure Pharmaceuticals Profit & Loss Annual
1,277.75 +21.55 (1.72%)Updated : 10 Jul 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 6,821.65 | 5,750.87 | 5,070.56 | 4,769.93 |
| Other Net | 67.26 | -21.27 | -14.68 | -15.92 |
| Diluted Weighted Average Shares | 18.70 | 18.91 | 18.91 | 18.91 |
| Depreciation/ Amortization | 384.13 | 312.41 | 260.12 | 244.86 |
| Operating Income | 1,074.35 | 907.39 | 915.25 | 1,085.46 |
| Net Income | 681.33 | 498.18 | 532.02 | 662.20 |
| Income Availableto Com Excl Extra Ord | 681.33 | 498.18 | 532.02 | 662.20 |
| Other Operating Expenses Total | 1,834.25 | 919.76 | 829.78 | 785.84 |
| Net Income Before Taxes | 971.35 | 727.23 | 747.21 | 972.55 |
| Minority Interest | -26.14 | -29.39 | -29.83 | -40.36 |
| Net Income After Taxes | 707.47 | 527.58 | 561.85 | 702.56 |
| Income Availableto Com Incl Extra Ord | 681.33 | 498.18 | 532.02 | 662.20 |
| Costof Revenue Total | 3,146.60 | 2,595.46 | 2,369.11 | 2,330.43 |
| Gross Profit | 4,749.39 | 4,062.79 | 3,616.70 | 3,524.95 |
| Interest Inc( Exp) Net- Non- Op Total | -170.26 | -166.08 | -153.03 | -96.58 |
| Unusual Expense( Income) | 10.38 | 9.93 | 6.15 | - |
| Diluted Net Income | 681.33 | 498.18 | 532.02 | 662.20 |
| DPS- Common Stock Primary Issue | 3.00 | - | - | - |
| Provisionfor Income Taxes | 263.88 | 199.65 | 185.37 | 269.99 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 681.33 | 498.18 | 532.02 | 662.20 |
| Total Revenue | 7,896.00 | 6,658.25 | 5,985.81 | 5,855.39 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 7,896.00 | 6,658.25 | 5,985.81 | 5,855.39 |
| Selling/ General/ Admin Expenses Total | 1,446.29 | 1,913.31 | 1,605.41 | 1,408.80 |
| Diluted Normalized EPS | 36.83 | 26.45 | 28.39 | 35.03 |
| Diluted EPS Excluding Extra Ord Items | 36.43 | 26.35 | 28.13 | 35.02 |
| Gain( Loss)on Saleof Assets | - | 7.19 | -0.33 | -0.41 |
*All figures in crores except per share values
Emcure Pharmaceuticals Quick Links
Emcure Pharmaceuticals Dividend Emcure Pharmaceuticals Bonus Emcure Pharmaceuticals News Emcure Pharmaceuticals AGM Emcure Pharmaceuticals Rights Emcure Pharmaceuticals Splits Emcure Pharmaceuticals Board Meetings Emcure Pharmaceuticals Key Metrics Emcure Pharmaceuticals Shareholdings Emcure Pharmaceuticals Balance Sheet Emcure Pharmaceuticals Cashflow Emcure Pharmaceuticals Q1 Results Emcure Pharmaceuticals Q2 Results Emcure Pharmaceuticals Q3 Results Emcure Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
12,666.00+197.40(1.58%)
853.95+13.15(1.56%)
161.05+2.05(1.29%)
1,975.00-43.00 (-2.13%)
1,612.95-20.95 (-1.28%)